{"id":2622,"date":"2019-10-21T20:34:44","date_gmt":"2019-10-22T00:34:44","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/the-irish-times-us-opioid-epidemic-the-260m-settlement\/"},"modified":"2022-06-27T02:33:34","modified_gmt":"2022-06-27T06:33:34","slug":"the-irish-times-us-opioid-epidemic-the-260m-settlement","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/pl\/biale-papiery\/the-irish-times-us-opioid-epidemic-the-260m-settlement\/","title":{"rendered":"The Irish Times: Epidemia opioid\u00f3w w USA i osada $260m"},"content":{"rendered":"<p>Four large drug companies reached a last-minute $260 million (\u20ac233 million) legal settlement over their role in the US opioid addiction epidemic, averting the first federal trial, which was scheduled to start on Monday morning in Cleveland, Ohio.<\/p>\n<p>The settlement covers drug distributors AmerisourceBergen, Cardinal Health and McKesson and Israel-based drugmake Teva Pharmaceutical Industries, and ends lawsuits by two Ohio counties.<\/p>\n<p>Hunter Shkolnik, an attorney for the counties, said Teva was paying $20 million in cash and would contribute $25 million worth of Suboxone, an opioid addiction treatment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cztery du\u017ce firmy farmaceutyczne osi\u0105gn\u0119\u0142y w ostatniej chwili ugod\u0119 prawn\u0105 w wysoko\u015bci $260 mln (233 mln EUR) w zwi\u0105zku z ich rol\u0105 w epidemii uzale\u017cnienia od opioid\u00f3w w USA, unikaj\u0105c pierwszego federalnego procesu, kt\u00f3ry mia\u0142\u2026<\/p>","protected":false},"featured_media":0,"menu_order":261,"template":"","whitepaper_category":[254,75,98,253],"whitepaper-source":[316],"class_list":["post-2622","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioid-epidemic","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper-source-the-irish-times"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepapers\/2622\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/media?parent=2622"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper_category?post=2622"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/pl\/wp-json\/wp\/v2\/whitepaper-source?post=2622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}